Our Vision: Conquering Cancer Together

  Our Vision: Conquering Cancer Together

Cancer Research: An Educational Look at Treatment Options

  • Wednesday, May 08, 2024
  • 12:00 PM - 1:00 PM
  • Zoom webinar - link included with registration


Registration is closed

 Vision: Conquer Cancer Together

Mission: Connecting people and resources to strengthen cancer prevention, detection and quality of life in Nebraska.

Cancer Research: An Educational Look at Treatment Options

Wednesday, May 8, 2024

12p-1p CST

About the Webinar: 

Cancer research helps patients live longer. According to the National Cancer Institute the number of cancer survivors is projected to increase by 24.4% to 22.5 million by 2032. This talk will provide an overview of cancer research with a focus on clinical trials and the important role they play in advancing cancer care. Join us to hear perspectives from local cancer researchers and a cancer survivor.

Learning Objectives: 

1) Describe what cancer research is and how it works.

2) Identify how clinical trial participation impacts the advancement of cancer care.

3) Discuss common barriers to clinical trial participation.

4) Illustrate the impact of cancer research on cancer patients and survivors.


Joel Michalski, MD, PhD, is a member of the American Society of Hematology, American Society of Clinical Oncology and completed all his education at the University of Nebraska Medical Center. Dr. Michalski is a medical oncologist at Nebraska Cancer Specialists in Omaha. He has a strong interest in how the immune system interacts with cancer, and how those interactions can be utilized to treat many cancers. The fields of hematology and oncology are complex, and he is committed to providing the best, high quality care that modern medicine has to offer, along with a sincere desire to treat people, and not just a disease. 

Apar Kishor Ganti, MD is a physician-scientist, who completed his medical training and a residency in Clinical Pharmacology in Pune, India. He subsequently completed an Internal Medicine residency, a Medical Oncology fellowship and a Master’s Program in Clinical and Translational Research in the United States. Dr. Ganti serves as the Associate Director of Clinical Research at the UNMC Fred and Pamela Buffett Cancer Center. Dr. Ganti’s research interests are focused on development of novel treatment approaches for patients who are not candidates for standard therapies. His laboratory is focused on evaluating new pathways in head and neck and lung cancer and identifying novel prognostic and predictive biomarkers for these malignancies.

Ashley Pedro is a Stage 4 Colon Cancer that was diagnosed at age 33 on February 24th, 2021. Throughout the last three years, she has had two surgeries, multiple procedures, radiation, been through so many chemo treatments she's lost count, and participated in two clinical trials. Although neither of the clinical trials helped in her cancer adventure, she knows the data they got from her participation gave them data to help others. She is currently on “Fruzaqla” a drug that was just FDA approved on November 8th, 2023. It was approved but first had to go through the clinical trial process and she is thankful for the people that participated in those trials as this is the only thing that has worked and is currently shrinking her tumors. Ashley shared, "There are several stages in the clinical trial process and sometimes it may feel like you are part of the testing process, but you are part of such a humbling experience and are saving lives!".


Continuing Education

1.0 Continuing Education Contact Hours awarded by Iowa Western Community College, Iowa Board of Nursing Provider #6

NC2 webinars are included as a member benefit. Non-members will be charged $25/webinar OR can join as a member for $25/year to access all webinars.

Information for webinar will be included with your confirmation email and calendar invite.

In order to help us better track webinar attendance, you will also need to enter your name and email via Zoom.


Special Thanks to our Sponsor: 

Nebraska Cancer Coalition © 2024  •  5100 N 27th Street, Suite A2, Lincoln, NE 68521 •  NC2 is a 501(c)3 non-profit organization

Powered by Wild Apricot Membership Software